RESUMO
AIM: of non-small cell lung cancer (non a small eelllungeaneer, NSCLC) patients with survival analysis and prognostic factors. METHODS: The research I our hospital from 2005 to September 2010 on the treatment of 275 cases of clinical data of patients with NSCLC, and its age, pathological type, clinical stage, lymph node micrometastasis on prognosis and treatment Investigation of influence, and to analyze the prognostic factors for patients. RESULTS: The patients in the family history, clinical stage and other factors after treatment for patients with poor prognostic factors after treatment for patients with poor prognostic factors for survival. The treatment of choice for the greatest impact factor. This group of patients selected surgery plus chemotherpy, chemotherapy + radiotherapy, chemotherapy and symptomatic treatment 4, in the survival rates of patients in the four groups was significantly different (P < 0.05). The patients age, clinical stage, lymph node micrometastasis in pathological type on the prognosis of patients was statistically significant. CONCLUSION: The treatment of non-small cell lung cancer is an important prognostic factor.
